The association of resilience with self-care and quality of life in people with chronic obstructive pulmonary disease: A cross-sectional study.

Aim: To investigate the association of resilience with self-care and quality of life in people with chronic obstructive pulmonary disease.

Design: Cross-sectional study.

Methods: Data were collected between February and May 2021.

Efficacy and Safety of Tacrolimus as Treatment for Bleeding Caused by Hereditary Hemorrhagic Telangiectasia: An Open-Label, Pilot Study.

Haploinsufficiency for Endoglin (ENG) and activin A receptor type II-like I (/ALK1) lead to the formation of weak and abnormal vessels in hereditary hemorrhagic telangiectasia (HHT). These cause epistaxis (nosebleeds) and/or gastrointestinal blood loss. In vitro in cultured endothelial cells, tacrolimus has been shown to increase ENG and ALK1 expression.